- Home
- MKTX vs CRL Comparison
MKTX vs CRL Comparison
Compare MKTX & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTX
- CRL
- Stock Information
- Founded
- MKTX 2000
- CRL 1947
- Country
- MKTX United States
- CRL United States
- Employees
- MKTX N/A
- CRL N/A
- Industry
- MKTX Investment Bankers/Brokers/Service
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MKTX Finance
- CRL Health Care
- Exchange
- MKTX Nasdaq
- CRL Nasdaq
- Market Cap
- MKTX 6.8B
- CRL 7.3B
- IPO Year
- MKTX 2004
- CRL 2000
- Fundamental
- Price
- MKTX $179.71
- CRL $156.98
- Analyst Decision
- MKTX Buy
- CRL Buy
- Analyst Count
- MKTX 11
- CRL 15
- Target Price
- MKTX $228.09
- CRL $186.64
- AVG Volume (30 Days)
- MKTX 675.9K
- CRL 763.8K
- Earning Date
- MKTX 11-05-2025
- CRL 11-05-2025
- Dividend Yield
- MKTX 1.69%
- CRL N/A
- EPS Growth
- MKTX N/A
- CRL N/A
- EPS
- MKTX 5.95
- CRL N/A
- Revenue
- MKTX $837,157,000.00
- CRL $4,028,615,000.00
- Revenue This Year
- MKTX $7.08
- CRL N/A
- Revenue Next Year
- MKTX $8.50
- CRL $2.16
- P/E Ratio
- MKTX $30.22
- CRL N/A
- Revenue Growth
- MKTX 7.67
- CRL N/A
- 52 Week Low
- MKTX $178.20
- CRL $91.86
- 52 Week High
- MKTX $296.68
- CRL $230.02
- Technical
- Relative Strength Index (RSI)
- MKTX 38.14
- CRL 48.62
- Support Level
- MKTX $179.87
- CRL $149.90
- Resistance Level
- MKTX $185.21
- CRL $159.78
- Average True Range (ATR)
- MKTX 4.21
- CRL 6.03
- MACD
- MKTX 0.39
- CRL -0.75
- Stochastic Oscillator
- MKTX 12.31
- CRL 43.04
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.